Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Cue Biopharma (CUE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cue Biopharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.360 -0.050    -3.55%
- Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 220,427
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.315 - 1.440
Cue Biopharma 1.360 -0.050 -3.55%

CUE Recent Sentiments

 
This page contains information on users’ sentiments for the Cue Biopharma stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 11, 2024 Gaby Gesa   1.680 Apr 15, 2024 @ 1.680 0.00%
Mar 21, 2024 Aldo Barozzi   1.900 Apr 12, 2024 @ 1.750 -7.89%
Jul 17, 2023 Ole Reinbach   4.620 Nov 30, 2023 @ 2.230 -51.73%
May 30, 2023 재혁 윤   4.160 Nov 30, 2023 @ 2.230 -46.39%
May 30, 2023 재혁 윤   4.160 Nov 30, 2023 @ 2.230 -46.39%
May 15, 2023 Gerd Käser   4.500 Nov 30, 2023 @ 2.230 -50.44%
May 04, 2023 Ed Murphy   4.610 Nov 30, 2023 @ 2.230 -51.63%
Apr 13, 2023 Danny Körner   3.580 May 09, 2023 @ 4.910 +37.15%
Sep 02, 2022 Jitendra Kulkarni   3.010 Sep 23, 2022 @ 2.650 -11.96%
Aug 24, 2022 Robbert Kuipers   2.950 Aug 29, 2022 @ 2.760 -6.44%
Apr 04, 2022 Graziano Zuntini   5.530 Apr 29, 2022 @ 3.960 -28.39%
Mar 17, 2022 Robbert Kuipers   5.500 Mar 21, 2022 @ 5.840 +6.18%
Feb 10, 2022 ابو عمر   6.470 Mar 04, 2022 @ 5.010 +22.57%
Aug 24, 2021 Jesus Ar   11.030 Sep 17, 2021 @ 12.910 +17.04%
Jul 14, 2021 Tsvetan Tsvetanov   10.480 Aug 06, 2021 @ 10.720 -2.29%
May 10, 2021 Piero Santoro   13.810 May 11, 2021 @ 13.550 +1.88%
Mar 30, 2021 Yernaz Adylbek   10.880 Apr 23, 2021 @ 12.200 +12.13%
Feb 09, 2021 Paco Parra Martinez   16.050 Mar 05, 2021 @ 13.050 -18.69%
Jan 26, 2021 john muldoon   14.100 Feb 19, 2021 @ 13.960 -0.99%
Dec 03, 2020 Paul Matthews   13.350 Dec 04, 2020 @ 13.480 +0.97%
Dec 02, 2020 Tsvetan Tsvetanov   14.330 Dec 25, 2020 @ 13.120 -8.44%
Sep 09, 2020 Tsvetan Tsvetanov   16.530 Oct 02, 2020 @ 15.600 -5.63%
Aug 12, 2020 Tsvetan Tsvetanov   20.820 Sep 04, 2020 @ 15.810 -24.06%
Jul 09, 2020 Tsvetan Tsvetanov   22.850 Jul 31, 2020 @ 18.910 -17.24%
Jun 08, 2020 Tsvetan Tsvetanov   26.250 Jul 03, 2020 @ 22.890 -12.80%
Jun 03, 2020 Karen Striley   28.110 Jun 26, 2020 @ 23.480 -16.47%
May 28, 2020 heriberto ramirez   27.520 Jun 08, 2020 @ 24.440 -11.19%
May 04, 2020 Etiolo Man   24.280 May 29, 2020 @ 27.680 +14.00%
May 01, 2020 Tsvetan Tsvetanov   24.000 May 22, 2020 @ 30.100 -25.42%
Apr 29, 2020 Yashpaul Satiya   27.140 May 22, 2020 @ 30.100 -10.91%
Mar 05, 2020 Paul Matthews   22.300 Mar 06, 2020 @ 20.800 +6.73%
Feb 21, 2020 Paul Matthews   19.960 Feb 24, 2020 @ 18.700 +6.31%
Feb 18, 2020 Norman Muldoon   18.010 Mar 13, 2020 @ 13.150 -26.99%
Feb 18, 2020 Paul Matthews   18.400 Feb 18, 2020 @ 17.990 +2.23%
Feb 10, 2020 Paul Matthews   18.850 Feb 16, 2020 @ 17.350 +7.96%
Feb 06, 2020 Sebastian Roig   16.450 Feb 28, 2020 @ 17.490 -6.32%
Jan 29, 2020 Andreas Schatz   16.340 Feb 21, 2020 @ 19.810 +21.24%
Jan 27, 2020 Weidong Jia   15.020 Feb 21, 2020 @ 19.810 +31.89%
Dec 11, 2019 Paul Matthews   13.150 Dec 12, 2019 @ 12.710 +3.35%
Dec 02, 2019 Paul Matthews   11.570 Dec 06, 2019 @ 11.330 +2.07%
Mar 22, 2019 Paul Matthews   8.400 Mar 22, 2019 @ 7.970 +5.12%
Feb 27, 2019 Việt Nguyễn   6.840 Mar 22, 2019 @ 7.950 +16.23%
Feb 01, 2019 владимир рад   5.250 Mar 03, 2019 @ 6.790 +29.33%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CUE Comments

Write your thoughts about Cue Biopharma
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tom Daniel
Tom Daniel Mar 09, 2021 9:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this expletive company... years and years of promoses. still nothing
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email